The global healthcare landscape is witnessing critical structural transformations, placing infectious disease management at the center of clinical priorities. According to recent comprehensive industry tracking, the global Anti-Infective Drugs Market—which was valued at USD 135 billion in 2022 and climbed toward USD 184.7 billion by 2030—is maintaining an architectural shift in momentum. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/